Why Pacira BioSciences, Inc. is positioning EXPAREL as a cost-saving tool in Medicare surgery

Find out how Pacira BioSciences, Inc.’s EXPAREL data could reduce opioid use and surgical costs in Medicare patients.

Find out how Pacira BioSciences, Inc.’s EXPAREL data could reduce opioid use and surgical costs in Medicare patients.

New HSS data challenge assumptions on aspirin, NSAIDs, and cefazolin in joint replacement. See what this means for bleeding, pain, and infection risk.